Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment
Clinical trial NCT03832348 · COMPLETED
Trial details
- NCT number
- NCT03832348
- Sponsor
- Centre Henri Becquerel
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2024-06-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.